RLBD (Real Brands) EBITDA Margin %: 0.00% (As of Mar. 2024)

What is Real Brands EBITDA Margin %?

Real Brands RLBD -90.00% EBITDA Margin % is 0.00% as of Mar. 2024.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Real Brands's EBITDA for the three months ended in Mar. 2024 was $-0.11 Mil. Real Brands's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, Real Brands's EBITDA margin for the quarter that ended in Mar. 2024 was 0.00%.

Real Brands (OTCPK:RLBD) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Real Brands EBITDA Margin % Related Terms

Real Brands EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Real Brands's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Real Brands EBITDA Margin % Chart

Real Brands Annual Data

Trend

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Get a 7-Day Free Trial

0.00

-24,484.00

-43,250.00

-7,190.91

-1,991.67

Real Brands Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBITDA Margin %	Get a 7-Day Free Trial															-3,272.73	-775.00	0.00	-694.44	0.00

RLBD vs NTRR, KOAN, CNNC: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Real Brands's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Real Brands EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Real Brands's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Real Brands's EBITDA Margin % falls into.

Save Embed

Real Brands EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Real Brands's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.195	/	0.06
	=	-1,991.67 %

Real Brands's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.114	/	0
	=	%

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of 0.00% mean?

Real Brands (RLBD) has a EBITDA Margin % of 0.00% as of Mar. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Real Brands and its competitors.

Is Real Brands' EBITDA Margin % too high?

Real Brands' current EBITDA Margin % is 0.00%.

How does Real Brands' EBITDA Margin % compare to NTRR and KOAN?

Real Brands' EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Drug Manufacturers company?

The median EBITDA Margin % among Drug Manufacturers companies is 12.47, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Real Brands and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Real Brands's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Real Brands stock overvalued right now?

Real Brands (RLBD) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Real Brands (RLBD), the current EBITDA Margin % is 0.00% as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Real Brands Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies NTRR KOAN CNNC SKYI NXEN THCT GCAN BSPK CBDY PLSH ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692

Address 12 Humbert Street, North Providence, RI, USA, 02991

Website https://www.realbrandsusa.com

Real Brands Inc is a publicly traded, vertically integrated, early entrant in the hemp-derived cannabinol (CBD) market that specializes in hemp CBD oil/isolate extraction, wholesaling of CBD oils and isolate, manufacturing, production, and sales of hemp-derived CBD consumer, celebrity brands, and white label products.